Anti-Allodynic Effect of Intracerebroventricularly Administered Antioxidant and Free Radical Scavenger in a Mouse Model of Orofacial Pain

Aims: To evaluate possible effects of the intracerebroventricular (icv) injection of either O-Tricyclo [5.2.1.02,6] dec-9-yl dithiocarbonate potassium salt (D609), a potent antioxidant and inhibitor of phosphatidylcholine specific phospholipase C (PtdCho-PLC) and acid sphingomyelinase (ASMase), or the spin trap/free radical scavenger N-tert-Butyl-a-phenylnitrone (PBN), on mechanical allodynia induced by facial carrageenan injection in mice. Methods: Balb/c mice received icv injection of D609/PBN plus facial carrageenan injection, and the number of face wash strokes to von Frey hair mechanical stimulation of the maxillary skin was quantified. PtdCho-PLC and ASMase activities were also assayed in the brainstem, thalamus, and somatosensory cortex. Results: Mice that received the icv injection of 10 nmol D609 plus facial carrageenan injection showed significantly fewer face wash strokes evoked by von Frey hair stimulation (indicating reduced mechanical allodynia) at 1 and 3 days post-injection, compared to mice that received icv injection of isotonic saline plus facial carrageenan injection. Mice that received icv injection of 1.13 µmol PBN plus facial carrageenan injection likewise showed significantly fewer face wash strokes after facial carrageenan injection, compared to isotonic saline-injected plus carrageenan-injected controls. D609 injection also resulted in significantly reduced ASMase activity in the brainstem, thalamus, and somatosensory cortex 3 days after injection, compared to controls. Conclusion: The icv injections of D609 and PBN were effective in reducing mechanical allodynia after facial carrageenan injection-induced pain. Together, the results point to a possible role of central nervous system sphingolipids and/or free radicals in orofacial pain.

acid sphingomyelinase; free radicals; mechanical allodynia; orofacial pain; phosphatidylcholine specific phospholipase C; reactive oxygen species; ROS

1. Yeo JF, Ong WY, Ling SF, Farooqui AA. Intracerebroventricular injection of phospholipases A2 inhibitors modulates allodynia after facial carrageenan injection in mice. Pain 2004;112:148–155.

2. Vahidy WH, Ong WY, Farooqui AA, Yeo JF. Effects of intracerebroventricular injections of free fatty acids, lysophospholipids, or platelet activating factor in a mouse model of orofacial pain. Exp Brain Res 2006;174: 781–785.

3. Galeotti N, Stefano GB, Guarna M, Bianchi E, Ghelardini

C. Signaling pathway of morphine induced acute thermal hyperalgesia in mice. Pain 2006;123:294–305.

4. Galeotti N, Bartolini A, Ghelardini C. The phospholipase C-IP3 pathway is involved in muscarinic antinociception. Neuropsychopharmacology 2003;28:888–897.

5. Balla T. Phosphoinositide-derived messengers in endocrine signaling. J Endocrinol 2006;188:135–153.

6. Farooqui AA, Horrocks LA. Signaling and interplay mediated by phospholipases A2, C, and D in LA-N-1 cell nuclei. Reprod Nutr Dev 2005;45:613–631.

7. Joseph EK, Levine JD. Caspase signalling in neuropathic and inflammatory pain in the rat. Eur J Neurosci 2004;20:2896–2902.

8. Park ES, Gao X, Chung JM, Chung K. Levels of mitochondrial reactive oxygen species increase in rat neuropathic spinal dorsal horn neurons. Neurosci Lett 2006;391:108–111.

9. Khattab MM. TEMPOL, a membrane-permeable radical scavenger, attenuates peroxynitrite- and superoxide anion-enhanced carrageenan-induced paw edema and hyperalgesia: A key role for superoxide anion. Eur J Pharmacol 2006;548:167–173.

10. Yeo JF, Ling SF, Tang N, Ong WY. Antinociceptive effect of CNS peroxynitrite scavenger in a mouse model of orofacial pain. Exp Brain Res 2008;184:435–438.

11. Kim HK, Park SK, Zhou JL, et al. Reactive oxygen species (ROS) play an important role in a rat model of neuropathic pain. Pain 2004;111:116–124.

12. Siniscalco D, Fuccio C, Giordano C, et al. Role of reactive oxygen species and spinal cord apoptotic genes in the development of neuropathic pain. Pharmacol Res 2007;55:158–166.

13. Lee I, Kim HK, Kim JH, Chung K, Chung JM. The role of reactive oxygen species in capsaicin-induced mechanical hyperalgesia and in the activities of dorsal horn neurons. Pain 2007;133:9–17.

14. Schwartz ES, Lee I, Chung K, Chung JM. Oxidative stress in the spinal cord is an important contributor in capsaicin- induced mechanical secondary hyperalgesia in mice. Pain 2008;138:514–524.

15. Zhou D, Lauderback CM, Yu T, Brown SA, Butterfield DA, Thompson JS. D609 inhibits ionizing radiation- induced oxidative damage by acting as a potent antioxidant. J Pharmacol Exp Ther 2001;298:103–109.

16. Tschaikowsky K, Meisner M, Schönhuber F, Rügheimer

E. Induction of nitric oxide synthase activity in phagocytic cells inhibited by tricyclodecan-9-yl-xanthogenate (D609). Br J Pharmacol 1994;113:664–668.

17. Simarro M, Calvo J, Vila JM, et al. Signaling through CD5 involves acidic sphingomyelinase, protein kinase C-zeta, mitogen-activated protein kinase kinase, and c-Jun NH2-terminal kinase. J Immunol 1999;162:5149–5155.

18. Koishi R, Yoshimura C, Kohama T, Serizawa N. Leustroducsin B activates nuclear factor-kappaB via the acidic sphingomyelinase pathway in human bone marrow-derived stromal cell line KM-102. J Interferon Cytokine Res 2002;22:343–350.

19. Strle K, Broussard SR, McCusker RH, et al. Proin-flammatory cytokine impairment of insulin-like growth factor I-induced protein synthesis in skeletal muscle myoblasts requires ceramide. Endocrinology 2004; 145:4592–4602.

20. Lauderback CM, Drake J, Zhou D, et al. Derivatives of xanthic acid are novel antioxidants: Application to synaptosomes. Free Radic Res 2003;37:3553–3565.

21. Sultana R, Newman S, Mohmmad-Abdul H, Keller JN, Butterfield DA. Protective effect of the xanthate, D609, on Alzheimer’s amyloid beta-peptide (1-42)-induced oxidative stress in primary neuronal cells. Free Radic Res 2004;38:449–458.

22. Kahle PJ, Shooter EM, Johnson RM, Verity AN. Phosphatidylcholine-specific phospholipase inhibitor D609 differentially affects MAP kinases and immediate-early genes in PC12 cells. Cell Signal 1998;10:321–330.

23. Luberto C, Hannun YA. Sphingomyelin synthase, a potential regulator of intracellular levels of ceramide and diacylglycerol during SV40 transformation. Does sphingomyelin synthase account for the putative phosphatidylcholine-specific phospholipase C? J Biol Chem 1998;273: 14550–14559.

24. Vos BP, Strassman AM, Maciewicz RJ. Behavioral evidence of trigeminal neuropathic pain following chronic constriction injury to the rat’s infraorbital nerve. J Neurosci 1994;14:2708–2723.

25. Vos BP, Hans G, Adriaensen H. Behavioral assessment of facial pain in rats: Face grooming patterns after painful and non-painful sensory disturbances in the territory of the rat’s infraorbital nerve. Pain 1998;76:173–178.

26. Chen G, Griffin M, Poyer JL, McCay PB. HPLC procedure for the pharmacokinetic study of the spin-trapping agent, alpha-phenyl-N-tert-butyl nitrone (PBN). Free Radic Biol Med 1990;9:93–98.

27. Lee I, Kim HK, Kim JH, Chung K, Chung JM. The role of reactive oxygen species in capsaicin-induced mechanical hyperalgesia and in the activities of dorsal horn neurons. Pain 2007;133:9–17.

28. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates, ed 5. Amsterdam: Elsevier, 2005.

29. Dallel R, Villanueva L, Woda A, Voisin D. Neurobiology of trigeminal pain. Med Sci 2003;19:567–574.

30. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248–254.

31. Xu M, Aita M, Chavkin C. Partial infraorbital nerve ligation as a model of trigeminal nerve injury in the mouse: Behavioral, neural, and glial reactions. J Pain 2008;9: 1036–1048.

32. Newton AC. Regulation of protein kinase C. Curr Opin Cell Biol 1997;9:161–167.

33. Coderre TJ. Contribution of protein kinase C to central sensitization and persistent pain following tissue injury. Neurosci Lett 1992;140:181–184.

34. Wajima Z, Hua XY, Yaksh TL. Inhibition of spinal protein kinase C blocks substance P-mediated hyperalgesia. Brain Res 2000;877:314–321.

35. Dai Q, Liu J, Chen J, Durrant D, McTntyre TM, Lee RM. Mitochondrial ceramide increases in UV-irradiated HeLa cells and is mainly derived from hydrolysis of sphingomyelin. Oncogene 2004;23:3650–3658.

36. Colombaioni L, Garcia-Gil M. Sphingolipid metabolites in neural signaling and function. Brain Res Brain Rev 2004;46:328–355.

37. Farooqui AA, Horrocks LA, Farooqui T. Interactions between neural membrane phospholipids and sphingolipids: A recipe for neural cell survival or suicide. J Neurosci Res 2007;85:1834–1850.

38. Joseph EK, Levine, JD. Mitochondrial electron transport in models of neuropathic and inflammatory pain. Pain 2006;121:105–114.

39. Yang MS, Jou I, Inn-Oc H, Joe E. Sphingomyelinase but not ceramide induces nitric oxide synthase expression in rat brain microglia. Neurosci Lett 2001;311:133–136.

40. Perluigi M, Joshi G, Sultana R, et al. In vivo protection by the xanthate tricyclodecan-9-yl-xanthogenate against amyloid beta-peptide (1-42)-induced oxidative stress. Neuroscience 2006;138:1161–1170.

41. Wang ZQ, Porreca F, Cuzzocrea S, et al. A newly identified role for superoxide in inflammatory pain. J Pharmacol Exp Ther 2004;309:869–878.